#VisualAbstract: Casirivimab and imdevimab reduced mortality in seronegative patients with COVID-19
1. All-cause mortality at 28 days was significantly higher in the usual care group compared to the casirivimab and imdevimab ...
1. All-cause mortality at 28 days was significantly higher in the usual care group compared to the casirivimab and imdevimab ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.